Patent · US Active

Compositions

US11684677B2 · kind B2 · utility

1Cited by
3References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 27, 2019
Grant dateJun 27, 2023
Priority date—
Expiry dateNov 22, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/94
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

There is provided inter alia a composition comprising a TNF-alpha binding polypeptide and an IL-6R binding polypeptide.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.